|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/50 | (2006.01) |
| A61K 47/12 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61K 47/14 | (2013.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 47/36 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 47/08 | (2006.01) | ||
| A61K 47/42 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 31/436 | (2013.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 31/55 | (2013.01) | ||
| A61K 47/14 | (2017.01) | ||
| A61K 38/13 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 9/0053 | (2013.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61K 47/44 | (2013.01) | ||
| A61K 47/44 | (2017.01) | ||
| A61K 9/1623 | (2013.01) | ||
| A61K 47/42 | (2017.01) | ||
| A61K 31/436 | (2006.01) | ||
| A61K 9/1664 | (2013.01) | ||
| A61K 38/13 | (2006.01) | ||
| A61K 9/1682 | (2013.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 9/5036 | (2013.01) | ||
| A61K 31/706 | (2006.01) | ||
| A61K 9/5057 | (2013.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/06 | (2018.01) |
| (11) | Number of the document | 3485876 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17802796.7 |
| Date of filing the European patent application | 2017-05-23 | |
| (97) | Date of publication of the European application | 2019-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2017/019167 |
| Date | 2017-05-23 |
| (87) | Number | WO 2017/204210 |
| Date | 2017-11-30 |
| (30) | Number | Date | Country code |
| 2016103212 | 2016-05-24 | JP |
| (72) |
ENDO, Norimasa , JP
HIRASAWA, Wataru , JP
MORI, Jun , JP
FUKASAWA, Takayuki , JP
|
| (73) |
Sunsho Pharmaceutical Co., Ltd. ,
1468, Atsuhara
Fuji-shi, Shizuoka 419-0201,
JP
|
| (54) | ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING PARTICULATE FORMULATION COMPRISING COMPOSITION |
| ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING PARTICULATE FORMULATION COMPRISING COMPOSITION |